Vascular wall-rather than platelet PGE1-pretreatment in-vivo (but not in-vitro) decreases thrombogenicity.
Karanikas
G
G
Department of Nuclear Medicine, University of Vienna, Austria.
Granegger
S
S
Schima
H
H
Sinzinger
H
H
D000527:Alprostadil / Q000494:pharmacology*; D000818:Animals; D001158:Arteries / Q000187:drug effects / Q000473:pathology / Q000502:physiology*; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D006487:Hemostasis / Q000187:drug effects / Q000502:physiology; D006801:Humans; D066298:In Vitro Techniques; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000473:pathology / Q000502:physiology*; D011817:Rabbits; D013927:Thrombosis / Q000517:prevention & control*
D000527:Alprostadil